These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 106941)

  • 1. Inhibition of passive lung anaphylaxis in the rat by AY-25,674.
    Greenberg R; Martel RR; Smorong K
    Can J Physiol Pharmacol; 1979 Jan; 57(1):48-52. PubMed ID: 106941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of passive anaphylaxis induced in the rat hind paw and peritoneal cavity by N-(2-oxo-3,5,7-cycloheptatrien-1-yl)-aminooxoacetic acid ethyl ester (AY-25,674).
    Martel PR; Klicius J; Pinski J
    Can J Physiol Pharmacol; 1978 Dec; 56(6):1005-10. PubMed ID: 743615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model of IgE-mediated passive pulmonary anaphylaxis in rats.
    Wex E; Thaler E; Blum S; Lamb D
    PLoS One; 2014; 9(12):e116166. PubMed ID: 25541997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of tachyphylaxis to disodium cromoglycate.
    Sung CP; Saunders HL; Krell RD; Chakrin LW
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):374-84. PubMed ID: 73515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy.
    Adolphson RL; Finkel MP; Robichaud LJ
    Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M; Imayoshi T; Goto K
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The difference in effect of predosing with antiallergic compounds between the rat PCA model and the monkey asthma model. Comparison of the effects of PRD-92-Ea and disodium cromoglycate.
    El-Azab J; Stewart PB
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):343-9. PubMed ID: 412794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-mediated anaphylactic bronchoconstriction in the guinea pig and the effect of disodium cromoglycate.
    Carney IF
    Int Arch Allergy Appl Immunol; 1976; 50(3):322-8. PubMed ID: 814102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A; Coutts S; Weinryb I
    Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
    Miller P; James GW
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs.
    Goto K; Terasawa M; Kadobe Y; Maruyama Y
    Jpn J Pharmacol; 1980 Aug; 30(4):537-47. PubMed ID: 6162988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianaphylactic agents. 1. 2-(Acylamino)oxazoles.
    Ross WJ; Harrison RG; Jolley MR; Neville MC; Todd A; Verge JP; Dawson W; Sweatman WJ
    J Med Chem; 1979 Apr; 22(4):412-7. PubMed ID: 430478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.